Literature DB >> 11388784

How many deleterious mutations are there in the human genome?

J A Morris1.   

Abstract

An estimate of the number of deleterious mutations in the human genome is made using data on the frequency of rare recessive disease in cousin marriages and in the general population. Sexual reproduction ensures that deleterious mutations are distributed at random in zygotes with an approximate Poisson distribution. The mean of this distribution is the sum of the mean number of deleterious mutations in zygotes which contribute to the next generation (Y) and the mean number of new mutations which arise in each human generation (X). The estimates are that X is between 1 and 2.6 and Y is between 12 and 32. A mathematical model based on redundancy is then used to predict how zygote survival will vary with the number of deleterious mutations. The form of this relationship is the same as that seen in experiments on cell survival following radiation-induced mutational damage and this provides independent support for this theoretical approach. The zygotes that survive to contribute to the next generation have a skewed distribution with a mean of Y. It is argued that the number of deleterious mutations in the genome is an important variable in health and disease. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11388784     DOI: 10.1054/mehy.2000.1200

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Information theory: a guide in the investigation of disease.

Authors:  J A Morris
Journal:  J Biosci       Date:  2001-03       Impact factor: 1.826

2.  The conservation of redundancy in genetic systems: effects of sexual and asexual reproduction.

Authors:  J A Morris; R D Morris
Journal:  J Biosci       Date:  2003-12       Impact factor: 1.826

3.  The Relationship between Runs of Homozygosity and Inbreeding in Jersey Cattle under Selection.

Authors:  Eui-Soo Kim; Tad S Sonstegard; Curtis P Van Tassell; George Wiggans; Max F Rothschild
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.